Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.36 |
| ▸ | FAAH | O00519 | 8/20 | 0.33 |
| ▸ | CCR5 | P51681 | 3/20 | 0.33 |
| ▸ | CES1 | P23141 | 6/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL907552 | 0.92 | CES2 (0.31) | CES2 | |
| Trifluoroacetic Acid SCHEMBL907470 | 0.90 | FAAH (0.34) | CES2FAAHCCR5CES1MEN1 | |
| Trifluoroacetic Acid SCHEMBL907385 | 0.87 | CCR5 (0.34) | CES2FAAHCCR5CES1MEN1 | |
| Trifluoroacetic Acid SCHEMBL907539 | 0.87 | CHRM2 (0.33) | CES2 | |
| SCHEMBL2903615 | 0.83 | — | — | |
| Trifluoroacetic Acid SCHEMBL907719 | 0.82 | CCR5 (0.32) | CCR5 | |
| Trifluoroacetic Acid SCHEMBL907787 | 0.82 | — | — | |
| Trifluoroacetic Acid SCHEMBL907247 | 0.81 | — | — | |
| Nitrous Acid SCHEMBL3446898 | 0.81 | — | — | |
| SCHEMBL3448803 | 0.81 | ALDH1A1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7875732-B2 | Quaternary ammonium salt, electrolyte, electrolyte, solution and electrochemical device | OTSUKA CHEMICAL CO., LTD. (JP) | 2011-01-25 | — | — | US | disclosed |
| US-20080050657-A1 | N-methoxymethyl-N-methylpyrrolidinium trifluoromethanesulfonate; high solubility in organic solvents, high electroconductivity, voltage resistance; environmentally friendly; use in lithium battery; double layer capacitors | STELLA CHEMIFA CORPORATION (JP) | 2008-02-28 | — | — | US | disclosed |
| EP-1837333-A1 | QUATERNARY AMMONIUM SALT, ELECTROLYTE, ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE | Otsuka Chemical Co., Ltd. (JP) | 2007-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080050657-A1 | N-methoxymethyl-N-methylpyrrolidinium trifluoromethanesulfonate; high solubility in organic solvents, high electroconductivity, voltage resistance; environmentally friendly; use in lithium battery; double layer capacitors | CACNA1F, KCNN2, KCNN3 | CES2 2006/4885FAAH 3568/4885CCR5 2124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.